Opioid Tolerance Treatment Market Size, Share, And Growth Report 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Opioid Tolerance Treatment Market, 2017-2025 (USD Million)
  • 2.2. Global Opioid Tolerance Treatment Market: Snapshot
•  
• Chapter 3. Global Opioid Tolerance Treatment Market - Industry Analysis
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Rising consumption of opioids for medical and non-medical purposes
    • 3.2.2. An increasing number of opioid prescriptions for therapeutic purposes
  • 3.3. Market Restraints
    • 3.3.1. Stringent procedures and protocols in the medical field
  • 3.4. Opportunities
    • 3.4.1. Government Funding and Support
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1.
    • Market attractiveness analysis, by Drug
    • 3.6.2. Market attractiveness analysis, by opioid tolerance type
    • 3.6.3. Market attractiveness analysis, by administration route
    • 3.6.4. Market attractiveness analysis, by end-user
    • 3.6.5.
    • Market attractiveness analysis, by region
•  
• Chapter 4. Global Opioid Tolerance Treatment Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Opioid Tolerance Treatment Market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New therapy launch
    • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
    • 4.2.4. Research and development and regional expansion
•  
• Chapter 5. Global Opioid Tolerance Treatment Market - Drug Analysis
  • 5.1. Global Opioid Tolerance Treatment Market: Drug overview
    • 5.1.1. Global Opioid Tolerance Treatment Market Revenue share, by Drug, 2018 and 2025
  • 5.2. NMDA Antagonists
    • 5.2.1. Global Opioid Tolerance Treatment Market for NMDA Antagonists, 2017-2025 (USD Million)
  • 5.3. Alpha2-Adrenoceptor Agonists
    • 5.3.1. Global Opioid Tolerance Treatment Market for Alpha2-Adrenoceptor Agonists, 2017-2025 (USD Million)
  • 5.4. Others
    • 5.4.1. Global Opioid Tolerance Treatment Market for others, 2017-2025 (USD Million)
•  
• Chapter 6. Global Opioid Tolerance Treatment Market - Opioid Tolerance Type Analysis
  • 6.1. Global Opioid Tolerance Treatment Market: Opioid Tolerance Type
    • 6.1.1. Global Opioid Tolerance Treatment Market Revenue share, by Opioid Tolerance Type, 2018 and 2025
  • 6.2. Innate Tolerance
    • 6.2.1. Global Opioid Tolerance Treatment Market for Innate Tolerance, 2017-2025 (USD Million)
  • 6.3. Acquired Tolerance
    • 6.3.1. Global Opioid Tolerance Treatment Market for Acquired Tolerance, 2017-2025 (USD Million)
•  
• Chapter 7. Global Opioid Tolerance Treatment Market - Administration Route Segment Analysis
  • 7.1. Global Opioid Tolerance Treatment Market: Administration Route overview
    • 7.1.1. Global Opioid Tolerance Treatment Market revenue share, by Administration Route, 2018 and 2025
  • 7.2. Enteral
    • 7.2.1. Global Opioid Tolerance Treatment Market for Enteral, 2017-2025 (USD Million)
  • 7.3. Parenteral
    • 7.3.1. Global Opioid Tolerance Treatment Market for Parenteral, 2017-2025 (USD Million)
•  
• Chapter 8. Global Opioid Tolerance Treatment Market - End-User Analysis
  • 8.1. Global Opioid Tolerance Treatment Market: End-User overview
    • 8.1.1. Global Opioid Tolerance Treatment Market revenue share, by End-User, 2018 and 2025
  • 8.2. Hospitals & ASCs
    • 8.2.1. Global Opioid Tolerance Treatment Market for Hospitals & ASCs, 2017-2025 (USD Million)
  • 8.3. Rehabilitation Centers
    • 8.3.1. Global Opioid Tolerance Treatment Market for Rehabilitation Centers, 2017-2025 (USD Million)
  • 8.4. Others
    • 8.4.1. Global Opioid Tolerance Treatment Market for Others, 2017-2025 (USD Million)
•  
• Chapter 9. Global Opioid Tolerance Treatment Market - Regional Analysis
  • 9.1. Global Opioid Tolerance Treatment Market: regional overview
    • 9.1.1. Global Opioid Tolerance Treatment Market Revenue share, by region, 2018 and 2025
  • 9.2. North America
    • 9.2.1. North America Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
    • 9.2.2. North America Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
    • 9.2.3. North America Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
    • 9.2.4. North America Opioid Tolerance Treatment Market Revenue, by end-user, 2017-2025 (USD Million)
    • 9.2.5. The U.S.
      • 9.2.5.1. The U.S. Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.2.5.2. The U.S. Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.2.5.3. The U.S. Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.2.5.4. The U.S. Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.2.6. Rest of North America
      • 9.2.6.1. Rest of North America Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.2.6.2. Rest of North America Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.2.6.3. Rest of North America Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.2.6.4. Rest of North America Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
    • 9.3.2. Europe Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
    • 9.3.3. Europe Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
    • 9.3.4. Europe Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.3.5. UK
      • 9.3.5.1. UK Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.3.5.2. UK Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.3.5.3. UK Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.3.5.4. UK Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.3.6. Germany
      • 9.3.6.1. Germany Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.3.6.2. Germany Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.3.6.3. Germany Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.3.6.4. Germany Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.3.7. France
      • 9.3.7.1. France Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.3.7.2. France Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.3.7.3. France Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.3.7.4. France Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.3.8. Rest of Europe
      • 9.3.8.1. Rest of Europe Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.3.8.2. Rest of Europe Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.3.8.3. Rest of Europe Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.3.8.4. Rest of Europe Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
    • 9.4.2. Asia Pacific Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
    • 9.4.3. Asia Pacific Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
    • 9.4.4. Asia Pacific Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.4.5. China
      • 9.4.5.1. China Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.4.5.2. China Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.4.5.3. China Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.4.5.4. China Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.4.6. Japan
      • 9.4.6.1. Japan Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.4.6.2. Japan Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.4.6.3. Japan Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.4.6.4. Japan Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.4.7. India
      • 9.4.7.1. India Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.4.7.2. India Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.4.7.3. India Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.4.7.4. India Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.4.8. Rest of Asia Pacific
      • 9.4.8.1. Rest of Asia Pacific Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.4.8.2. Rest of Asia Pacific Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.4.8.3. Rest of Asia Pacific Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.4.8.4. Rest of Asia Pacific Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
    • 9.5.2. Latin America Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
    • 9.5.3. Latin Global Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
    • 9.5.4. Latin Global Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.5.5. Brazil
      • 9.5.5.1. Brazil Global Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.5.5.2. Brazil Global Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.5.5.3. Brazil Global Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.5.5.4. Brazil Global Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
    • 9.5.6. Rest of Latin America
      • 9.5.6.1. Rest of Latin America Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
      • 9.5.6.2. Rest of Latin America Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
      • 9.5.6.3. Rest of Latin America Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
      • 9.5.6.4. Rest of Latin America Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
  • 9.6. The Middle East and Africa
    • 9.6.1. The Middle East and Africa Opioid Tolerance Treatment Market Revenue, by Drug, 2017-2025 (USD Million)
    • 9.6.2. The Middle East and Africa Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017-2025 (USD Million)
    • 9.6.3. The Middle East and Africa Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017-2025 (USD Million)
    • 9.6.4. The Middle East and Africa Opioid Tolerance Treatment Market Revenue, by End-User, 2017-2025 (USD Million)
•  
• Chapter 10. Company Profile
  • 10.1. Boehringer Ingelheim International
    • 10.1.1. Overview
    • 10.1.2. Financials
    • 10.1.3. Product portfolio
    • 10.1.4. Business strategy
    • 10.1.5. Recent developments
  • 10.2. GlaxoSmithKline
    • 10.2.1. Overview
    • 10.2.2. Financials
    • 10.2.3. Product portfolio
    • 10.2.4. Business strategy
    • 10.2.5. Recent developments
  • 10.3. Teva Pharmaceutical Industries
    • 10.3.1. Overview
    • 10.3.2. Financials
    • 10.3.3. Product portfolio
    • 10.3.4. Business strategy
    • 10.3.5. Recent developments
  • 10.4. Mylan N.V.
    • 10.4.1. Overview
    • 10.4.2. Financials
    • 10.4.3. Product portfolio
    • 10.4.4. Business strategy
    • 10.4.5. Recent developments
  • 10.5. Otsuka Pharmaceutical
    • 10.5.1. Overview
    • 10.5.2. Financials
    • 10.5.3. Product portfolio
    • 10.5.4. Business strategy
    • 10.5.5. Recent developments
  • 10.6. Johnson & Johnson Services
    • 10.6.1. Overview
    • 10.6.2. Financials
    • 10.6.3. Product portfolio
    • 10.6.4. Business strategy
    • 10.6.5. Recent developments
  • 10.7. Aurobindo Pharma
    • 10.7.1. Overview
    • 10.7.2. Financials
    • 10.7.3. Product portfolio
    • 10.7.4. Business strategy
    • 10.7.5. Recent developments
  • 10.8. Pfizer
    • 10.8.1. Overview
    • 10.8.2. Financials
    • 10.8.3. Product portfolio
    • 10.8.4. Business strategy
    • 10.8.5. Recent developments
  • 10.9. Acorda Therapeutics
    • 10.9.1. Overview
    • 10.9.2. Financials
    • 10.9.3. Product portfolio
    • 10.9.4. Business strategy
    • 10.9.5. Recent developments
  • 10.10. ZydusCadila
    • 10.10.1. Overview
    • 10.10.2. Financials
    • 10.10.3. Product portfolio
    • 10.10.4. Business strategy
    • 10.10.5. Recent developments
    • 10.10.6. Business strategy
    • 10.10.7. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Opioid Tolerance Treatment Market Revenue, 2017–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Opioid Tolerance Treatment Market attractiveness analysis, by Drug
6. Global Opioid Tolerance Treatment Market attractiveness analysis, by opioid tolerance type
7. Global Opioid Tolerance Treatment Market attractiveness analysis, by Administration Route 
8. Global Opioid Tolerance Treatment Market attractiveness analysis, by End-User
9. Global Opioid Tolerance Treatment Market: market attractiveness analysis, by region
10. Company market share analysis, 2018
11. Global Opioid Tolerance Treatment Market revenue share by Drug, 2018 and 2025
12. Global Opioid Tolerance Treatment Market revenue share by NMDA Antagonists, 2017–2025 (USD Million)
13. Global Opioid Tolerance Treatment Market revenue share by Alpha2-Adrenoceptor Agonists, 2017–2025 (USD Million)
14. Global Opioid Tolerance Treatment Market revenue share by Others, 2017–2025 (USD Million)
15. Global Opioid Tolerance Treatment Market revenue share by Opioid Tolerance Type, 2018 and 2025
16. Global Opioid Tolerance Treatment Market revenue share by Innate Tolerance, 2017–2025 (USD Million)
17. Global Opioid Tolerance Treatment Market revenue share by Acquired Tolerance, 2017–2025 (USD Million)
18. Global Opioid Tolerance Treatment Market revenue share by Administration Route, 2018 and 2025
19. Global Opioid Tolerance Treatment Market revenue share by Enteral, 2017–2025 (USD Million)
20. Global Opioid Tolerance Treatment Market revenue share by Parenteral, 2017–2025 (USD Million)
21. Global Opioid Tolerance Treatment Market revenue share by End-User, 2018 and 2025
22. Global Opioid Tolerance Treatment Market revenue share by Hospitals & ASCs, 2017–2025 (USD Million)
23. Global Opioid Tolerance Treatment Market revenue share by Rehabilitation Centers, 2017–2025 (USD Million)
24. Global Opioid Tolerance Treatment Market revenue share by Others, 2017–2025 (USD Million)

Table Of Tables

List of Tables

1. Global Opioid Tolerance Treatment Market: Market Snapshot
2. Drivers of the Global Opioid Tolerance Treatment Market: impact analysis 
3. Restraints of the Global Opioid Tolerance Treatment Market: impact analysis
4. North America Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
5. North America Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
6. North America Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
7. North America Opioid Tolerance Treatment Market Revenue, by End-user, 2017–2025 (USD Million)
8. The U.S. Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
9. The U.S. Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
10. The U.S. Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
11. The U.S. Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
12. Rest of North America Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
13. Rest of North America Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
14. Rest of North America Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
15. Rest of North America Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
16. Europe Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
17. Europe Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
18. Europe Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
19. Europe Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
20. UK Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
21. UK Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
22. UK Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
23. UK Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
24. Germany Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
25. Germany Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
26. Germany Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
27. Germany Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
28. France Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
29. France Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
30. France Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
31. France Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
32. Rest of Europe Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
33. Rest of Europe Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
34. Rest of Europe Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
35. Rest of Europe Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
36. Asia Pacific Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
37. Asia Pacific Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
38. Asia Pacific Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
39. Asia Pacific Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
40. China Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
41. China Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
42. China Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
43. China Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
44. Japan Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
45. Japan Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
46. Japan Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
47. Japan Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
48. India Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
49. India Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
50. India Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
51. India Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
52. Rest of Asia Pacific Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
53. Rest of Asia Pacific Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
54. Rest of Asia Pacific Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
55. Rest of Asia Pacific Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
56. Latin America Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
57. Latin America Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
58. Latin America Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
59. Latin America Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
60. Brazil Global Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
61. Brazil Global Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
62. Brazil Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
63. Brazil Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
64. Rest of Latin America Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
65. Rest of Latin America Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
66. Rest of Latin America Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
67. Rest of Latin America Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)
68. The Middle East and Africa Opioid Tolerance Treatment Market Revenue, by Drug, 2017–2025 (USD Million)
69. The Middle East and Africa Opioid Tolerance Treatment Market Revenue, by Opioid Tolerance Type, 2017–2025 (USD Million)
70. The Middle East and Africa Opioid Tolerance Treatment Market Revenue, by Administration Route, 2017–2025 (USD Million)
71. The Middle East and Africa Opioid Tolerance Treatment Market Revenue, by End-User, 2017–2025 (USD Million)